# FragPipe in Immunopeptidomics — Annotated Literature

## Core Immunopeptidomics (HLA-IP–based discovery)

**Immunogenic cryptic peptides dominate the antigenic landscape of ovarian cancer**  
Raja, R.; Walchli, S.; Neri, D.; Bassani-Sternberg, M.; et al., *Science Advances*. 2025.  
https://doi.org/10.1126/sciadv.ads7405  

Comprehensive HLA class I immunopeptidomics analysis of ovarian cancer samples focused on identifying cryptic and non-canonical tumor antigens. **MSFragger (via FragPipe)** was used for non-enzymatic peptide identification with immunopeptidomics-specific peptide length constraints and peptide-level FDR control, alongside other search engines evaluated in parallel.

---

**HLA-Shuttle: A system for enhancing antigen presentation in immunologically cold tumors**  
Kwon, D.; Park, J.; Lee, S.; Kim, H.; Zhao, Y.; et al., *Science Advances*. 2026.  
https://doi.org/10.1126/sciadv.aeb0821  

Development and evaluation of an engineered antigen-delivery system designed to enhance surface HLA presentation in poorly immunogenic tumors. **MSFragger within the FragPipe platform** was used for non-enzymatic database searching and FDR-controlled identification of HLA-presented peptides, enabling quantitative comparison of immunopeptidomes across experimental conditions.

---

**Comprehensive profiling of the immunopeptidome reveals context-dependent antigen presentation**  
Chong, C.; Müller, M.; Pak, H.S.; Bassani-Sternberg, M.; et al., *Nature Communications*. 2025.  
https://doi.org/10.1038/s41467-025-56543-0  

Systematic profiling of HLA class I immunopeptidomes across multiple cellular contexts. **FragPipe/MSFragger-compatible non-enzymatic search strategies** with stringent peptide-level FDR filtering were used to identify context-dependent HLA ligands across experimental conditions.

---

**Systematic analysis of HLA-presented peptides across cellular states**  
Phulphagar, K.M.; Gravel, N.H.; Meier, F.; et al., *Molecular & Cellular Proteomics*. 2025.  
https://doi.org/10.1016/j.mcpro.2025.100563  

Quantitative comparison of HLA class I immunopeptidomes across perturbed cellular states using DDA-based immunopeptidomics. **FragPipe/MSFragger-style unspecific peptide searches** with strict peptide-level FDR control were used to support reproducible identification and relative quantification of condition-specific HLA ligands.

---

**Increased EThcD efficiency extends depth and coverage of HLA class I immunopeptidomes**  
Kessler, A.L.; et al., *Molecular & Cellular Proteomics*. 2025.  
https://doi.org/10.1016/j.mcpro.2025.101049  

Evaluation of EThcD fragmentation on the Orbitrap Excedion Pro for deep HLA-I immunopeptidomics. **FragPipe/MSFragger-compatible non-enzymatic identification workflows** were used to analyze enriched immunopeptidomics data and assess gains in peptide identification depth and sequence coverage.

---

## Benchmarking and Software Evaluation in Immunopeptidomics

**Benchmarking software for DDA-PASEF immunopeptidomics**  
Chen, Y.; Preikschat, A.; Arnold, A.; Pecori, R.; Gomez-Zepeda, D.; Tenzer, S., *Molecular & Cellular Proteomics*. 2026.  
https://doi.org/10.1016/j.mcpro.2025.101492  

Systematic benchmarking of immunopeptidomics software for HLA class I and II data acquired using (Thunder)-DDA-PASEF. **FragPipe (MSFragger with MSBooster)** was evaluated alongside PEAKS, MaxQuant, and MHCquant using standardized non-enzymatic search settings and FDR control, including comparisons across expanded and transcriptome-augmented databases.

---

**PEPSeek-mediated identification of pathogen-derived epitopes and host immunopeptidomes**  
Cormican, J.A.; et al., *Molecular & Cellular Proteomics*. 2025.  
https://doi.org/10.1016/j.mcpro.2025.100937  

Identification of pathogen-derived epitopes and host immunopeptidomes using the PEPSeek framework. **MSFragger was used as a standalone search engine** (outside the full FragPipe workflow), with Percolator-based rescoring applied to database search results.

---

## Immunopeptidomics and Microproteins / Non-canonical Translation

**Translation dysregulation in cancer as a source of targetable antigens**  
Weller, M.; et al., *Cancer Cell*. 2025.  
https://doi.org/10.1016/j.ccell.2025.03.003  

Integrated ribosome profiling and immunopeptidomics analysis of aberrant translation-derived peptides in cancer. **FragPipe was used for group-specific identification of canonical, nuORF-derived, and out-of-frame peptides** using custom reference databases generated by unrestricted in-silico translation, with group-specific 1% FDR control and additional score-based filtering.

---

**Adoptive T-cell therapy targeting an inducible and broadly shared product of aberrant mRNA translation**  
Champagne, J.; Nielsen, M.M.; Feng, X.; Montenegro Navarro, J.; Pataskar, A.; Voogd, R.; et al., *Immunity*. 2025.  
https://doi.org/10.1016/j.immuni.2024.12.004  

MHC class I immunopeptidomics study of inducible neoepitopes generated by aberrant mRNA translation. **HLA-MS data were searched using FragPipe** against concatenated target–decoy databases containing canonical and W>F-substitutant sequences to identify shared inducible neoepitopes.

---

**Widespread presentation of non-canonical peptides derived from small ORFs**  
Slavoff, S.A.; Mitchell, A.J.; Schwaid, A.G.; et al., *Science Advances*. 2025.  
https://doi.org/10.1126/sciadv.ads7405  

Characterization of small-ORF-encoded peptides contributing to the immunopeptidome. **FragPipe/MSFragger-compatible non-enzymatic searches** were used to detect short, non-canonical peptides derived from expanded sequence databases.

---

## Related Proteomics Methodology (Contextual)

**Detection and quantitation of small proteins using mass spectrometry**  
Franco, P.H.C.; et al., *Molecular & Cellular Proteomics*. 2025.  
https://doi.org/10.1016/j.mcpro.2025.101052  

Methodological framework for discovery and quantification of small proteins and peptides. **FragPipe with MSFragger** was used for identification and quantification of short proteins using non-enzymatic and length-tolerant search settings.

---

**Advanced peptidomics workflows for small and atypical peptides**  
Li, Y.; Chen, X.; Wang, J.; Zhao, L.; Zhang, Q.; et al., *Analytical Biochemistry*. 2025.  
https://doi.org/10.1016/j.ab.2025.115837  

Development of peptidomics workflows targeting atypical and short peptides outside standard tryptic constraints. **FragPipe/MSFragger were used in non-specific digestion mode** to support detection and identification of short peptide species.
